Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
OK Science and Technology Co., Ltd. (001223.SZ)
Jiujiang, CN
Based in Jiujiang, China, OK Science and Technology Co., Ltd., founded in 2011, specializes in developing and manufacturing industrial machinery. The company engineers and produces a full range of equipment for the tissue paper industry, encompassing core paper production as well as converting and packaging lines for various finished goods such as facial tissues, napkins, toilet paper, kitchen towels, and pocket tissues. Additionally, their product portfolio includes specialized machines for the fabrication of disposable surgical masks and KN95 masks.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.41% | -8.43% | +3.55% | +2.28% | +6.69% | +17.23% | +44.62% | +15.12% | +0.02% | +0.02% | +0.02% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Industrial - Machinery: +7.4%+120.0% ★ Q1'26: +28.3% (vs Q1'25)
-
EPS growth Industrial - Machinery: +15.6%+18.9% ★ Q1'26: -23.3% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Machinery: +38.2%+1.0% Q1'26: +4.5% (vs Q1'25)
-
EBIT margin Industrial - Machinery: +10.0%+8.3% Q1'26: +14.7% (vs Q1'25)
-
ROIC Industrial - Machinery: +6.8%+2.8% Q1'26: +7.7% (vs Q1'25)
-
Share dilution Industrial - Machinery: +0.0%0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Machinery: -0.65×1.50× ★ Q1'26: 1.36× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|
| Revenue |
434.47M
est: 1.20B (-63.7%)
|
955.87M
est: 1.88B (-49.0%)
|
| EBITDA |
70.07M
est: 409.30M (-82.9%)
|
136.44M
est: 641.60M (-78.7%)
|
| EBIT |
33.08M
est: 343.74M (-90.4%)
|
79.37M
est: 538.83M (-85.3%)
|
| Net Income |
34.29M
est: 552.59M (-93.8%)
|
40.86M
|
| SGA |
63.35M
est: 112.00M (-43.4%)
|
29.03M
est: 175.56M (-83.5%)
|
| EPS |
0.37
est: 5.92 (-93.8%)
|
0.44
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Fusheng Hu | Vice Chairman & General Manager | — | male |
| Hanning Yuan | Deputy GM & Director | — | male |
| Jiansheng Hu | Chairman & Chief Engineer | — | male |
| Xiao Bing Cao | Deputy General Manager | — | male |
| Zhen Chen | Financial Director, Accounting Supervisor & Secretary to the Board | — | male |
| Zhihui Li | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 001223.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
